中国の皮膚真菌症治療薬市場

◆英語タイトル:Anti Dermatomycosis Skin Drugs Markets in China
◆商品コード:AMID5083
◆発行会社(リサーチ会社):Asia Market Information & Development
◆発行日:2015年1月
◆ページ数:193
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:中国
◆販売価格オプション(消費税別)
Single User(1名使用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Global Site License(社内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAsia Market Information & Development社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Asia Market Information & Development社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

China’s demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

【レポートの目次】

[TABLE OF CONTENTS]

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

Anti Dermatomycosis Skin Drugs Industry Structure
Market Size
Market Growth Driver
Anti Dermatomycosis Skin Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

Overview
Demand of Anti Dermatomycosis Skin Drugs by Region
Anti Dermatomycosis Skin Drugs Sales Volume
Fluconazole Sales Volume and Market Share
Itraconazole Sales Volume and Market Share
Terbinafine Sales Volume and Market Share
Econazole Sales Volume and Market Share
Miconazole Nitrate Sales Volume and Market Share
Amphotericin B Sales Volume and Market Share
Ketoconazole Sales Volume and Market Share
Clotrimazole Sales Volume and Market Share
Caspofungin Sales Volume and Market Share
Other Anti Dermato Mycosis Skin Drugs Sales Volume and Market Share
Anti Dermatomycosis Skin Drugs Imports and Exports
Pricing Trends

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Northeast
North
Southeast
Central
Southwest
Northwest
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds

VI. MARKET ENTRY CHANNELS

China Market Entry Overview

China’s Distribution System
Anti Peptic Ulcer Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry

Export to China
Indirect Export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

Anti Dermatomycosis Skin Drugs Producer Profiles and Directory

[LIST OF TABLES]

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS

Anti Dermatomycosis Skin Drugs Sales Volume
Major Producer Facility Locations
Major Anti Dermatomycosis Skin Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investments

IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

Total Anti Peptic Ulcer Drugs Consumption
Consumer Spending Trend
The Structure of Per Capita Expenditure in the Northeast of China
The Structure of Per Capita Expenditure in the North of China
The Structure of Per Capita Expenditure in the Southeast of China
The Structure of Per Capita Expenditure in the Central of China
The Structure of Per Capita Expenditure in the Southwest of China
The Structure of Per Capita Expenditure in the Northwest of China
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds

[LIST OF CHARTS]

I. INTRODUCTION

Anti Dermatomycosis Skin Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

Anti Dermatomycosis Skin Drugs Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

Anti Dermatomycosis Skin Drugs Sales Volume
Worldwide Anti Dermatomycosis Skin Drugs Demand by Region
Fluconazole Sales Volume and Market Share
Itraconazole Sales Volume and Market Share
Terbinafine Sales Volume and Market Share
Econazole Sales Volume and Market Share
Miconazole Sales Volume and Market Share
Amphotericin B Sales Volume and Market Share
Ketoconazole Sales Volume and Market Share
Clotrimazole Sales Volume and Market Share
Caspofungin Sales Volume and Market Share
Other Anti Dermatomycosis Skin Drugs Sales Volume and Market Share
Anti Dermatomycosis Skin Drugs Import, Export and Net Import
Fluconazole Import, Export and Net Import
Itraconazole Import, Export and Net Import
Terbinafine Import, Export and Net Import
Econazole Import, Export and Net Import
Miconazole Nitrate Import, Export and Net Import
Amphotericin B Import, Export and Net Import
Ketoconazole Import, Export and Net Import
Clotrimazole Import, Export and Net Import
Caspofungin Import, Export and Net Import
Other Import, Export and Net Import

V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK

VI. MARKETING STRATEGIES

China’s Distribution Channel



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 中国の皮膚真菌症治療薬市場(Anti Dermatomycosis Skin Drugs Markets in China)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆